(Q38099053)

English

Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials

scientific article published on 16 April 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Pseudomonas aeruginosa

0 references

cystic fibrosis

0 references

systematic review

1 reference

based on heuristic

inferred from title

author name string

Luis Máiz

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Rosa M Girón

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Casilda Olveira

3

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Esther Quintana

4

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Adelaida Lamas

5

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Dolores Pastor

6

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Rafael Cantón

7

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Josep Mensa

8

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

language of work or name

0 references

publication date

16 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Expert Opinion on Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

1135-1149

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Cystic fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Tobramycin for inhalation in cystic fibrosis: Beyond respiratory improvements

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: the EVOLVE trial

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Evidence based medicine: what it is and what it isn't

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Regulatory aspects of Phase 3 endpoints for new inhaled antibiotics for cystic fibrosis patients with chronic Pseudomonas aeruginosa infections

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Treatment of lung infection in patients with cystic fibrosis: current and future strategies

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.790366

21 January 2018

Identifiers

10.1517/14656566.2013.790366

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38099053&oldid=2148854598"